ME News and Press, 23andMe Holding Co. From 04/23/24

2024-04-23 05:21:00 ET We recently learned that spatial technology company Matterport (NASDAQ: MTTR) , which provides the space-mapping technology used for 3D home tours and many other applications, has agreed to be acquired by real estate giant CoStar (NASDAQ: CSGP) . T...

A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 7.2% to $0.04 on volume of 426,309,096 shares PROSHARES TRUST (SQQQ) rose 1.8% to $12.07 on volume of 171,048,374 shares AGBA Group Holding Limited (AGBA) rose 157.5% to $1.03 on volume of 121,894,6...

SOUTH SAN FRANCISCO, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, has been made aware that Anne Wojcicki, Chief Executive Officer, Co-Founder, and Chair of the Board of Directors of 23andMe, is considering mak...

2024-04-18 06:52:32 ET Summary Proposed bill may fast track TikTok's divestment from ByteDance or face a U.S. ban. Micron Technology to receive funding from the U.S. for chipmaking projects. 23andMe CEO eyes taking DNA-testing company private. Listen below or on the ...

2024-04-18 04:44:39 ET More on 23andMe 23andMe (ME) Q3 2024 Earnings Call Transcript 23andMe falls 20% after earnings, breakup speculation Seeking Alpha's Quant Rating on 23andMe Historical earnings data for 23andMe Read the full article on Seeking ...

2024-04-15 22:15:03 ET Citigroup analyst issues NEUTRAL recommendation for ME on April 15, 2024 08:50PM ET. The previous analyst recommendation was Neutral. ME was trading at $0.4016 at issue of the analyst recommendation. Historical Analyst Recommendations Latest ...

23ME-01473, antibody targeting ULBP6: Data will be presented on the discovery and biology of ULBP6, and the potential to restore natural killer and T cell-mediated anti-tumor immunity by targeting ULBP6 23ME-00610, antibody targeting CD200R1: Preclinical data will be presented on targetin...

2024-03-24 03:23:00 ET If you're an individual investor who wants to invest like a billionaire fund manager, I've got good news. Following billionaires is relatively easy because the U.S. Securities and Exchange Commission makes anyone who manages over $100 million in assets report their tr...

23ME-01473 (‘1473) seeks to restore anti-tumor immunity through NK and T cells by blocking the immunosuppressive effects of soluble ULBP6 ‘1473 also induces Fc receptor-mediated killing of ULBP6-expressing cancer cells through enhanced effector function SOUTH S...

SOUTH SAN FRANCISCO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, released an exciting new feature for 23andMe+ Premium and Total Health members, that uncovers DNA connections to 335 unique historical individu...